Skip to Main Content
Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 2010, Issue 1
December 4 2010
Issue Cover

Table of Contents

Ham-Wasserman Lecture

The Brain-Bone-Blood Triad: Traffic Lights for Stem-Cell Homing and Mobilization
Tsvee Lapidot,Orit Kollet
View Articletitled, The Brain-Bone-Blood Triad: Traffic Lights for Stem-Cell Homing and Mobilization

Acute Lymphoid Leukemia

Minimal Residual Disease in Acute Lymphoblastic Leukemia
Dario Campana
View Articletitled, Minimal Residual Disease in Acute Lymphoblastic Leukemia
Treating the “Older” Adult With Acute Lymphoblastic Leukemia
David I. Marks
View Articletitled, Treating the “Older” Adult With Acute Lymphoblastic Leukemia
Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Wendy Stock
View Articletitled, Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Aplastic Anemia

Telomere Biology and Telomere Diseases: Implications for Practice and Research
Neal S. Young
View Articletitled, Telomere Biology and Telomere Diseases: Implications for Practice and Research
Aplastic Anemia: First-line Treatment by Immunosuppression and Sibling Marrow Transplantation
Jakob R. Passweg,Judith C.W. Marsh
View Articletitled, Aplastic Anemia: First-line Treatment by Immunosuppression and Sibling Marrow Transplantation
Alternative Donor Transplantation for Aplastic Anemia
Mary Eapen,Mary M. Horowitz
View Articletitled, Alternative Donor Transplantation for Aplastic Anemia

Challenges in Acute Myeloid Leukemia

New Prognostic Markers in Acute Myeloid Leukemia: Perspective from the Clinic
James M. Foran
View Articletitled, New Prognostic Markers in Acute Myeloid Leukemia: Perspective from the Clinic
New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia
Hugo F. Fernandez
View Articletitled, New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia
Treating the Elderly Patient with Acute Myelogenous Leukemia
Selina M. Luger
View Articletitled, Treating the Elderly Patient with Acute Myelogenous Leukemia

Chronic Lymphocytic Leukemia

Novel Insights into the Biology of CLL
Mark C. Lanasa
View Articletitled, Novel Insights into the Biology of CLL
Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia
Richard R. Furman
View Articletitled, Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia
Treatment of Younger Patients with Chronic Lymphocytic Leukemia
Alessandra Ferrajoli
View Articletitled, Treatment of Younger Patients with Chronic Lymphocytic Leukemia
Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion
Wei Ding,Alessandra Ferrajoli
View Articletitled, Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion

Clinical Advances in Hodgkin Lymphoma

Upcoming Diagnostic and Therapeutic Developments in Classical Hodgkin's Lymphoma
Kristie A. Blum
View Articletitled, Upcoming Diagnostic and Therapeutic Developments in Classical Hodgkin's Lymphoma
The Past: What We Have Learned in the Last Decade
Peter Borchmann,Andreas Engert
View Articletitled, The Past: What We Have Learned in the Last Decade
The Present: Optimizing Therapy—Too Much or Too Little?
Nancy L. Bartlett
View Articletitled, The Present: Optimizing Therapy—Too Much or Too Little?

Clinical Impact of Targeted Therapies in Myeloproliferative Neoplasms

Assessing New Therapies and Their Overall Impact in Myelofibrosis
Ruben A. Mesa
View Articletitled, Assessing New Therapies and Their Overall Impact in Myelofibrosis
Chronic Myeloid Leukemia 2010: Where Are We Now and Where Can We Go?
Jerald P. Radich
View Articletitled, Chronic Myeloid Leukemia 2010: Where Are We Now and Where Can We Go?
Rethinking Disease Definitions and Therapeutic Strategies in Essential Thrombocythemia and Polycythemia Vera
Claire Harrison
View Articletitled, Rethinking Disease Definitions and Therapeutic Strategies in Essential Thrombocythemia and Polycythemia Vera

Consultative Hematology: Hemostasis and Thrombosis

Thrombocytopenia in the Intensive Care Unit Patient
Andreas Greinacher,Kathleen Selleng
View Articletitled, Thrombocytopenia in the Intensive Care Unit Patient
Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants
Agnes Y.Y. Lee
View Articletitled, Thrombosis in Cancer: An Update on Prevention, Treatment, and Survival Benefits of Anticoagulants
Evidence-Based Mini-Review: Should All Patients with Idiopathic Venous Thromboembolic Events Be Screened Extensively for Occult Malignancy?
Rachel Rosovsky,Agnes Y.Y. Lee
View Articletitled, Evidence-Based Mini-Review: Should All Patients with Idiopathic Venous Thromboembolic Events Be Screened Extensively for Occult Malignancy?
Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting
Aaron C. Logan,Lawrence T. Goodnough
View Articletitled, Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting

Consultative Hematology: The Pregnant Patient

Pregnancy and Commonly Used Drugs in Hematology Practice
Gideon Koren,Michael Lishner
View Articletitled, Pregnancy and Commonly Used Drugs in Hematology Practice
Consultative Hematology: The Pregnant Patient Pregnancy Loss
Shannon M. Bates
View Articletitled, Consultative Hematology: The Pregnant Patient Pregnancy Loss
Evidence Base for the Management of Venous Thromboembolism in Pregnancy
Marc Rodger
View Articletitled, Evidence Base for the Management of Venous Thromboembolism in Pregnancy

Grant Writing for Junior Faculty

Preparing Basic and Translational Grant Proposals: Thoughts from the Trenches
Jeffrey J. Molldrem
View Articletitled, Preparing Basic and Translational Grant Proposals: Thoughts from the Trenches
Tips for Writing Successful Patient-Oriented Research Career Development Awards
Stephanie J. Lee
View Articletitled, Tips for Writing Successful Patient-Oriented Research Career Development Awards
Hematology Grants Workshop
David A. Williams
View Articletitled, Hematology Grants Workshop

Hemophilia

The Aging Patient with Hemophilia: Complications, Comorbidities, and Management Issues
Claire Philipp
View Articletitled, The Aging Patient with Hemophilia: Complications, Comorbidities, and Management Issues
Alternative Strategies for Gene Therapy of Hemophilia
Robert R. Montgomery,Qizhen Shi
View Articletitled, Alternative Strategies for Gene Therapy of Hemophilia
Hemophilia: New Protein Therapeutics
Steven W. Pipe
View Articletitled, Hemophilia: New Protein Therapeutics

Issues in Thrombosis Management and Anticoagulation

Duration of Anticoagulation: Applying the Guidelines and Beyond
Kenneth A. Bauer
View Articletitled, Duration of Anticoagulation: Applying the Guidelines and Beyond
The Post-Thrombotic Syndrome
Susan R. Kahn
View Articletitled, The Post-Thrombotic Syndrome
Warfarin Versus New Agents: Interpreting the Data
Jack Ansell
View Articletitled, Warfarin Versus New Agents: Interpreting the Data

Issues of Toxicity in Allogeneic Bone Marrow Transplantation

Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation
Mohamad Mohty,Jane F. Apperley
View Articletitled, Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation
Comorbidities and Hematopoietic Cell Transplantation Outcomes
Mohamed L. Sorror
View Articletitled, Comorbidities and Hematopoietic Cell Transplantation Outcomes
Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation
Margaret Bevans
View Articletitled, Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation

Lymphoma: Translating Basic Science into Therapy

Host Factors for Risk and Survival in Lymphoma
Sandeep S. Dave
View Articletitled, Host Factors for Risk and Survival in Lymphoma
Novel Agents for Follicular Lymphoma
John P. Leonard,Peter Martin
View Articletitled, Novel Agents for Follicular Lymphoma
Signal Transduction Inhibitor Therapy for Lymphoma
Thomas E. Witzig,Mamta Gupta
View Articletitled, Signal Transduction Inhibitor Therapy for Lymphoma

Marrow Responses to Aging and Inflammation

Anemia in Elderly Patients: An Emerging Problem for the 21st Century
Gary J. Vanasse,Nancy Berliner
View Articletitled, Anemia in Elderly Patients: An Emerging Problem for the 21<sup>st</sup> Century
Anemia of Inflammation
Cindy N. Roy
View Articletitled, Anemia of Inflammation
Hematologic Disorders after Solid Organ Transplantation
Eileen P. Smith
View Articletitled, Hematologic Disorders after Solid Organ Transplantation

Multiple Myeloma

Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy
Adam D. Cohen,Raymond L. Comenzo
View Articletitled, Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy
Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: New Insights into Pathophysiology and Epidemiology
Ola Landgren
View Articletitled, Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: New Insights into Pathophysiology and Epidemiology
Relapsed Multiple Myeloma
Sagar Lonial
View Articletitled, Relapsed Multiple Myeloma
Evidence-Based Mini-Review: Treatment Options for Patients with Relapsed/Refractory Myeloma Previously Treated with Novel Agents and High-Dose Chemotherapy and Autologous Stem-Cell Transplantation
Nina Shah,Sagar Lonial
View Articletitled, Evidence-Based Mini-Review: Treatment Options for Patients with Relapsed/Refractory Myeloma Previously Treated with Novel Agents and High-Dose Chemotherapy and Autologous Stem-Cell Transplantation

Myelodysplastic Syndromes

How Much? How Frequent? How Long? A Clinical Guide to New Therapies in Myelodysplastic Syndromes
William Blum
View Articletitled, How Much? How Frequent? How Long? A Clinical Guide to New Therapies in Myelodysplastic Syndromes
Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?
Mark A. Schroeder,William Blum
View Articletitled, Evidence-Based Mini-Review: Should Patients Over the Age of 60 with INT-2 or High-Risk Myelodysplastic Syndrome Undergo Allogeneic Stem Cell Transplantation Prior to Progression to Acute Myelogenous Leukemia?
Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome
Corey Cutler
View Articletitled, Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome
Prognosis of Myelodysplastic Syndromes
Guillermo Garcia-Manero
View Articletitled, Prognosis of Myelodysplastic Syndromes

Parenteral Iron Therapy—Taking the Rust Off

Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Michael Auerbach,Harold Ballard
View Articletitled, Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Iron Deficiency and Heart Disease: Ironclad Evidence?
Jeffrey L. Carson,John W. Adamson
View Articletitled, Iron Deficiency and Heart Disease: Ironclad Evidence?
Parenteral Iron Therapy in Cancer-Associated Anemia
David H. Henry
View Articletitled, Parenteral Iron Therapy in Cancer-Associated Anemia

Pediatric Malignancies

Childhood Myelodysplastic Syndrome: Focus on the Approach to Diagnosis and Treatment of Juvenile Myelomonocytic Leukemia
Mignon L. Loh
View Articletitled, Childhood Myelodysplastic Syndrome: Focus on the Approach to Diagnosis and Treatment of Juvenile Myelomonocytic Leukemia
Pediatric Acute Lymphoblastic Leukemia: Is There Still a Role for Transplant?
Stella M. Davies,Parinda A. Mehta
View Articletitled, Pediatric Acute Lymphoblastic Leukemia: Is There Still a Role for Transplant?
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
Meinolf Suttorp,Frédéric Millot
View Articletitled, Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation

Platelet Disorders

Immune Thrombocytopenia
Adam Cuker,Douglas B. Cines
View Articletitled, Immune Thrombocytopenia
Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?
Adam Cuker,Douglas B. Cines
View Articletitled, Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?
Understanding and Evaluating Platelet Function
Lawrence Brass
View Articletitled, Understanding and Evaluating Platelet Function
Thrombocytopenia in Pregnancy
Keith R. McCrae
View Articletitled, Thrombocytopenia in Pregnancy

Sickle Cell

Neurobiological Mechanisms of Pain in Sickle Cell Disease
Zaijie J. Wang,Diana J. Wilkie,Robert Molokie
View Articletitled, Neurobiological Mechanisms of Pain in Sickle Cell Disease
Sickle-Cell Pain: Advances in Epidemiology and Etiology
Wally R. Smith,Marshall Scherer
View Articletitled, Sickle-Cell Pain: Advances in Epidemiology and Etiology
Evidence-Based Mini-Review: Are Systemic Corticosteroids an Effective Treatment for Acute Pain in Sickle Cell Disease?
L. Vandy Black,Wally R. Smith
View Articletitled, Evidence-Based Mini-Review: Are Systemic Corticosteroids an Effective Treatment for Acute Pain in Sickle Cell Disease?
Sickle-Cell Trait: Novel Clinical Significance
Nigel S. Key,Vimal K. Derebail
View Articletitled, Sickle-Cell Trait: Novel Clinical Significance

Supportive Care in Plasma Cell Dyscrasias

Dealing with Neuropathy in Plasma-Cell Dyscrasias
Pieter Sonneveld,Joost L.M. Jongen
View Articletitled, Dealing with Neuropathy in Plasma-Cell Dyscrasias
Renal Insufficiency and Failure
Meletios A. Dimopoulos,Evangelos Terpos
View Articletitled, Renal Insufficiency and Failure
Thrombosis in Multiple Myeloma
Sigurdur Yngvi Kristinsson
View Articletitled, Thrombosis in Multiple Myeloma

Thalassemia

Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside
Paritha Arumugam,Punam Malik
View Articletitled, Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside
Update on Iron Chelators in Thalassemia
Ellis J. Neufeld
View Articletitled, Update on Iron Chelators in Thalassemia
Hematopoietic Stem Cell Transplantation in Thalassemia
Emanuele Angelucci
View Articletitled, Hematopoietic Stem Cell Transplantation in Thalassemia

Transfusion Medicine: Transfusion Support in Trauma―Military and Civilian Approaches

Trauma Blood Management: Avoiding the Collateral Damage of Trauma Resuscitation Protocols
Timothy Hannon
View Articletitled, Trauma Blood Management: Avoiding the Collateral Damage of Trauma Resuscitation Protocols
Optimal Use of Blood Products in Severely Injured Trauma Patients
John B. Holcomb
View Articletitled, Optimal Use of Blood Products in Severely Injured Trauma Patients
Logistics of Massive Transfusions
Thomas G. DeLoughery
View Articletitled, Logistics of Massive Transfusions

Understanding and Managing Ultra High-Risk Hematological Malignancies

High Cytogenetic or Molecular Genetic Risk Acute Myeloid Leukemia
Elihu Estey
View Articletitled, High Cytogenetic or Molecular Genetic Risk Acute Myeloid Leukemia
Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia
Stephan Stilgenbauer,Thorsten Zenz
View Articletitled, Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia
Ultra High-Risk Myeloma
Hervé Avet-Loiseau
View Articletitled, Ultra High-Risk Myeloma
All Issues
Targeted medical therapies for vascular anomalies
T-cell–based therapies for treating relapsed or refractory mantle cell lymphoma
Transplant in ALL: who, when, and how?
Ph− ALL: immunotherapy in upfront treatment
Ph+ ALL: new approaches for upfront therapy
  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal